Whoops, looks like the CBO underestimated the cost of Obama Care
by $500 Billion. What else is new.
In addition the NYT reported that most Pharma is cutting Research and Development because of the govt pushing generics, which do zero R+D, and
the many govt. regulations.
Pfizer is cutting 30% of it's R+D as a generic Lipitor will be available in November.
There goes the future miracle drugs that so many younger people were
looking forward to extending their quality of older life and the best medical
care in the world.